|
|
|
Volumn 61, Issue 9, 2002, Pages 209-210
|
|
The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
RALOXIFENE;
TAMOXIFEN;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HUMAN;
ORGANIZATION AND MANAGEMENT;
PATIENT PARTICIPATION;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
UNITED STATES;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
ELIGIBILITY DETERMINATION;
FEMALE;
HAWAII;
HUMANS;
PATIENT PARTICIPATION;
RALOXIFENE;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TAMOXIFEN;
|
|
EID: 0036718266
PISSN: 00178594
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
